A unique investigation is underway in Sancti Spiritus, central Cuba, to provide new evidence on the efficacy of this drug»
DIABETIC FOOT ULCER
Mexico Registers Cuban Medication for Diabetic Patients
The registration of the pharmaceutical was announced in Havana in the first meeting of the Mexico-Cuba Health Cooperation Group»
Heberprot-p Might Soon Be Available for US Patients
According to BioCubaFarma enterprise, it is hoped that the Cuban developed medication will soon be available for patients in the United States»
Heberprot-P Treatment Benefits Thousands in Cuba
Heberprot-p was created by a team of researchers from the Center for Genetic Engineering and Biotechnology (CIGB)»
Cuba’s Heberprot-P Granted Health Registration in 23 Countries
Unique in the world to treat advanced foot ulcers in diabetic patients, the Cuban drug Heberprot-P has already been registered in 23 countries, it was informed today»
Over 31,000 Cuban Patients Benefit from Heberprot-P
Cuba reduced by over 78 percent the relative risk of amputation due to diabetic foot ulcers, thanks to a comprehensive program of care for these patients that includes the use of the drug Heberprot-P.»
Sancti Spiritus Outstanding in Heberprot-P Treatment Actions
Heberprot-P is a unique drug developed in Cuba.»
Ecuadorians Benefit with Cuban Heberprot-p
The Cuban product Heberprot-p, to cure complaints resulting from diabetes, is welcomed in Ecuador for the results reported by patients with treatment in this South American country.»
Clinical Trials against Cancer Applied in Sancti Spiritus, Cuba
Some 70 patients in Sancti Spiritus province suffering from different carcinogenic pathologies are included in the various clinical trials developed in the Cuban central territory, as part of the treatment against cancer, disease which consitutes the first cause of death in the region.»
Cuban Medication Tested in Europe
The Cuba-made medication Heberprot-P, used in the treatment of diabetic foot ulcers, has entered the second phase of clinical trials in Europe.»